(Q47380968)

15 January 2018

title

Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma (English)

1 reference

15 January 2018

1 reference

Surena F Matin

1

1 reference

15 January 2018

Vitaly Margulis

2

1 reference

15 January 2018

Ashish Kamat

3

1 reference

15 January 2018

Christopher G Wood

4

1 reference

15 January 2018

H Barton Grossman

5

1 reference

15 January 2018

Gordon A Brown

6

1 reference

15 January 2018

Colin P N Dinney

7

1 reference

15 January 2018

Randall Millikan

8

1 reference

15 January 2018

Arlene O Siefker-Radtke

9

1 reference

15 January 2018

language of work or name

English

0 references

publication date

1 July 2010

1 reference

15 January 2018

published in

Cancer

1 reference

15 January 2018

volume

116

1 reference

15 January 2018

issue

13

1 reference

15 January 2018

page(s)

3127-3134

1 reference

15 January 2018

Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre Rare Cancer Network study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Neoadjuvant chemotherapy for locally advanced urothelial cancer of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Comparing lymphadenectomy during radical nephroureterectomy: open versus laparoscopic

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Importance of node dissection in relation to neoadjuvant and adjuvant therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Evaluation for surrogacy of end points by using data from observational studies: tumor downstaging for evaluating neoadjuvant chemotherapy in invasive bladder cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Ureteroscopic management of upper tract transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Transitional cell carcinoma of the ureter and renal pelvis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Transitional cell carcinoma of the upper urinary tract: spectrum of imaging findings

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Grade of hydronephrosis and tumor diameter as preoperative prognostic factors in ureteral transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25050

7 January 2021

Identifiers

DOI

10.1002/CNCR.25050

1 reference

15 January 2018

PubMed ID

20564621

1 reference

15 January 2018